Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · Real-Time Price · USD
0.383
+0.000 (0.08%)
At close: Apr 28, 2026, 4:00 PM EDT
0.381
-0.002 (-0.63%)
After-hours: Apr 28, 2026, 7:38 PM EDT
Ensysce Biosciences Employees
As of December 31, 2025, Ensysce Biosciences had 10 total employees, including 8 full-time and 2 part-time employees. The number of employees increased by 2 or 25.00% compared to the previous year.
Employees
10
Change (1Y)
2
Growth (1Y)
25.00%
Revenue / Employee
$506,665
Profits / Employee
-$1,017,570
Market Cap
3.55M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| AIM ImmunoTech | 21 |
| VivoSim Labs | 14 |
| Azitra | 13 |
| Revelation Biosciences | 9 |
| Artelo Biosciences | 7 |
| Galmed Pharmaceuticals | 6 |
| Alzamend Neuro | 6 |
| GRI Bio | 4 |
ENSC News
- 12 days ago - Ensysce Biosciences Secures IRB Approval of Final Phase of PF614-MPAR-102 Clinical Study - Accesswire
- 21 days ago - Ensysce Biosciences Secures Second Financing From 2025 Agreement to Advance Breakthrough Pain Programs - Accesswire
- 4 weeks ago - Ensysce Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results - Accesswire
- 7 weeks ago - Ensysce Biosciences Initiates Live "Ask Me Anything" (AMA) Session Highlighting Growth and Future Plans - Accesswire
- 2 months ago - Ensysce Biosciences Announces First Peer-Reviewed Clinical Publication Demonstrating Oral Overdose Protection with MPAR(R) Technology - Accesswire
- 2 months ago - Tiny Pain-Focused Biotech Ensysce Biosciences Surges Amid Strategic Review - Benzinga
- 2 months ago - Ensysce Biosciences Initiates Review of Strategic Alternatives to Enhance Shareholder Value - Accesswire
- 2 months ago - Ensysce Biosciences Invited to Participate in Upcoming Scientific and Industry Events - Accesswire